Apimeds Pharmaceuticals US Inc. has announced key additions to its executive leadership team. Dr. Susan Kramer has been appointed as Senior Vice President of Development, bringing over 30 years of experience in biopharmaceutical research. Brian Peters joins as the Head of the ai² Division, overseeing the strategy and launch of the company's innovation platform. Dr. Kramer will manage all product development activities, while Peters will focus on strategic initiatives for Apimeds' ai² platform.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.